Rifampin is a nonspecific CYP450 inducer that may:
A) Lead to toxic levels of rifampin and must be monitored closely
B) Cause toxic levels of drugs, such as oral contraceptives, when coadministered
C) Induce the metabolism of drugs, such as oral contraceptives, leading to therapeutic failure
D) Cause nonspecific changes in drug metabolism
Correct Answer:
Verified
Q1: Genetic testing for VCORC1 mutation to assess
Q3: Genetic polymorphisms account for differences in metabolism,
Q4: Up to 21% of Asians are ultra-rapid
Q5: Carbamazepine has a Black Box Warning recommending
Q6: Pharmacogenetic testing is required by the U.S.
Q7: A provider may consider testing for CYP2D6
Q8: Patients who have a poor metabolism phenotype
Q9: A genetic variation in how the metabolite
Q10: Ultra-rapid metabolizers of drugs may have:
A) To
Q11: Warfarin resistance may be seen in patients
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents